Upcoming Medical Conferences in New YorkSearch Criteria : United States of America New York
Sep 12, 2019 | AMA PRA Ca 6.25 | New York, New York
Sexual Health, HIV Prevention, and Primary Care in 2019 is organized by International Antiviral Society (IAS-USA) and will be held on Sep 12, 2019 at TKP New York Conference Center, New York, United States of America. This CME Conference has been approved for a maximum of 6.25 AMA PRA Category 1 Credits™. Description: This new course will focus on maintaining health for people with or at risk for HIV infection. This includes initiating and monitoring the use of preexposure prophylaxis (PrEP), sexual health including management and prevention of sexually transmitted infections (STIs), antiretroviral therapy during conception and pregnancy, and appropriate vaccines against preventable diseases. The course will address the notable increase in STIs that has paralleled increased uptake of PrEP. In convening this course, we will address the shift in primary responsibility for managing PrEP and STIs from HIV and infectious disease clinicians to primary care and internal medicine practitioners, as well as the need for widespread education around PrEP, STIs, and prevention throughout the medical community. Learning Objectives After participating in the activity, learners will be better able to: • Describe the emerging epidemiology, clinical presentations and management of the most common sexually transmitted infections (STIs) in the era of biomedical prevention • Describe the fundamentals of staging, serology, and treatment of syphilis • Determine which patients might benefit from pre-exposure prophylaxis (PrEP), and initiate and monitor use of PrEP for uninfected patients at risk for HIV infection • Apply newly available data to antiretroviral strategies for the management of established HIV infection in the context of conception and pregnancy • Apply newly available data to provide specific immunization guidance based on an individual’s immunologic status and assessed risk
Sep 13 - 15, 2019 | CME 24.00 | New York, New York
7th Annual Intensive Board Review in Gastroenterology and Hepatology is organized by Icahn School of Medicine at Mount Sinai (ISMMS) and will be held from Sep 13 - 15, 2019 at Leon and Norma Hess Center for Science and Medicine, New York City, New York, United States of America. This Conference has been approved for a maximum of 24.0 AMA PRA Category 1 Credits TM. Course Description: This is a three day course that was developed using a case-based question and answer format designed to replicate clinical scenarios. This course will provide an update on the latest diagnostic and therapeutic issues in gastroenterology and hepatology. Additional details will be posted as soon as they are available.
Sep 20, 2019 | New York, New York
SSTAR 2019 Fall Clinical Case Conference is organized by Society for Sex Therapy and Research (SSTAR) and will be held on Sep 20, 2019 at Millennium Times Square New York, New York, United States of America. Additional details will be posted as soon as they are available.
Sep 21, 2019 | New York, New York
Regional Summit Series on Acute Leukemias is organized by Oncology Meeting Innovations (OMI) and will be held on Sep 21, 2019 at New York, United States of America. Key Topics: • Discuss the current treatment landscape for acute leukemias • Examine the evolving genomic landscape of AML and MDS • Analyze therapies in late-stage development and how they will be utilized as treatment options for AML, ALL, and CML • Engage with leading experts to deliberate newest practices and novel therapies. Additional details will be posted as soon as they are available.
S2 - Advanced Evaluation & Manipulation of Pelvis, Lumbar & Thoracic Spine Including Thrust by USAHS (Sep 21 - 22, 2019)
Sep 21 - 22, 2019 | CME 18.00 | USD $495 | New York, New York
S2 - Advanced Evaluation & Manipulation of Pelvis, Lumbar & Thoracic Spine Including Thrust is organized by University of St. Augustine for Health Sciences (USAHS) and will be held from Sep 21 - 22, 2019 at New York, United States of America. Hours: 18 or 1.8 CEUs (includes 3 online hours) or 2 graduate credits Prerequisite: S1; Intro S2 Webinar is included with S2 Who Attends: Physical Therapists Description: Anatomy and biomechanics of the lumbar spine, thoracic spine, rib cage and the pelvis are discussed. Review and modification of techniques from S1 - Spinal Evaluation and Manipulation, along with the instruction of additional techniques are provided. An in-depth presentation on the syndromes of the lumbar spine and their treatment is instructed. The utilization of biomechanical and anatomical principles for the enhancement of patient care through manipulation and exercise is emphasized, as is the patient’s role in his/her own welfare. Learning Objectives: At the completion of this seminar, the attendee should be able to: • conduct a detailed physical examination of the lumbar, thoracic spine and pelvis • describe the mechanisms and characteristics of spinal pain and the behavior of pain patients • perform manipulation to the lumbar, thoracic spine/ribs and pelvis • discuss and present cases with spinal dysfunction • describe indications and contraindications of spinal manipulation • discuss the role of therapeutic exercise and preventative measures in the management of spinal dysfunction especially with regard to spinal stabilization
Sep 28, 2019 | AMA PRA Ca 8.25 | USD $75 | New York, New York
3rd Annual New York Cardio-Endo-Renal Collaborative (NY CERC) is organized by Physicians' Education Resource, LLC (PER) and will be held on Sep 28, 2019 at The Westin New York at Times Square, New York, United States of America. This educational activity is directed toward cardiologists, endocrinologists, specialty nurse practitioners, specialty physician assistants, certified diabetes educators, other specialty allied health professionals, nephrologists, and other health care professionals (HCPs). Accreditation/Credit Designation: Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This activity is approved for 8.25 AMA PRA Category 1 Credit™. Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669 for 8.25 Contact Hours. Description: New York Cardio-endo-renal Collaborative (NY CERC) focuses primarily on the strategic and novel approaches to management of integrated Cardiometabolic Diseases. This highly pragmatic and engaging conference blends in cutting-edge information delivered by expert academic physicians whom through a multitude of “challenging cases” provide the latest clinical updates related to state-of-the-art treatment in patient care. This conference will offer you the opportunity to advance your understanding and knowledge of chronic cardiometabolic and associated comorbidities. Learning Objectives: At the conclusion of this activity, the participant should be better prepared to: • Discuss clinical strategies for evaluation and diagnosis of patients presenting with cardiac, endocrine, and renal disease • Evaluate the rationale behind current and emerging testing used in the stratification of cardiometabolic risk in order to optimize the use of current and emerging agents or therapeutic strategies • Recognize and devise strategies to manage treatment-related adverse events and side effects in care of patients with cardiac, endocrine, and renal disease • Discern the potential clinical impact of recent clinical trial data on management of cardiac, endocrine, and renal disease • Identify current strategies and recent advancements in the prevention of cardiometabolic disorders • Assess barriers to care of patients with cardiac, endocrine, and renal disease • Employ strategies for patient counseling to improve education, preventative practices, adherence, and self-management.
Oct 03 - 06, 2019 | New York, New York
Oct 24 - 25, 2019 | AMA PRA Category 1 10.75 | USD $399 | New York, New York
12th International Congress on Myeloproliferative Neoplasms (MPNs) is organized by Melton Medical Education, LLC and will be held from Oct 24 - 25, 2019 at The Westin New York at Times Square, New York City, New York, United States of America. Target Audience: The 12th International Congress on MPNs is specifically designed for hematologists, medical oncologists, and other healthcare professionals (physicians, clinicians, physicians-in-training, oncology nurses, pharmacists, physician assistants, etc.) involved and/or interested in the therapeutic management of patients with myeloproliferative neoplasms and chronic myeloid leukemia. Accreditation: The Medical Society of the State of New York designates this live activity for a maximum of 10.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. ABIM MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 10.75 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Description: Since the inaugural Congress in 2001, this meeting has become the premier forum for discussion on the latest advances in myeloproliferative neoplasms (MPNs). This year, Congress will focus on timely topics of interest to hematologists and oncologists who treat patients with these rare disorders. The Congress program format will utilize case presentations to highlight the essential features of MPN pathophysiology, diagnosis, and management, as well as the roles of next-generation sequencing and the MPN driver mutation and allele burden in clinical decision making. In addition to defining the role of pegylated interferon and its long-acting derivatives in MPN therapy, the role of immunotherapy in the MPNs and novel agents for MPN treatment will be reviewed New this year will be a discussion of the management of accelerated and blast phase MPN, patient selection for bone marrow transplantation, and how to integrate MPN patient symptom scores with therapeutic planning. Congress attendees will have the opportunity to participate in a variety of educational formats including didactic sessions, case reviews, poster sessions and oral abstract presentations, as well as multiple networking and one-on-one discussion opportunities. To allow more time for participant questions, time has also been allotted for a panel discussion with Congress faculty. Educational Objectives: After participating in this program, participants should be able to: • Describe underlying molecular and genetic events involved in MPNs and how these events could be utilized in the clinic. • Discuss the role and utilization of current approved therapies in MPNs, as well as the potential role of agents in development. • Assess how to manage symptoms and therapy-associated adverse events for patients with MPNs. • Outline the current treatment strategies (including treatment termination) for patients with chronic myeloid leukemia (CML). Additional details will be posted as soon as they are available.
Oct 26 - 27, 2019 | New York, New York
ASCP Fall Psychopharmacology Update: State-of-the-Art Meeting is organized by American Society of Clinical Psychopharmacology (ASCP) and will be held from Oct 26 - 27, 2019 at The Roosevelt Hotel, New York City, New York, United States of America. Additional details will be posted as soon as they are available.
Dec 06, 2019 | New York, New York
4th Annual Intraoperative Imaging Technologies for Cancer Detection and Treatment is organized by Memorial Sloan Kettering Cancer Center (MSKCC) and will be held on Dec 06, 2019 at Zuckerman Research Center, New York, United States of America. Overview The overall goal of the course is to upgrade the learner on current and next generation image-guided intraoperative technologies for improving cancer detection, treatment, and patient outcomes. It will include didactic lectures and hands-on workshops featuring the latest technological innovations. This course is directed towards surgical oncologists, radiologists, pathologists, engineers, research scientists and technologists. Objectives • Enhance understanding of the role of optical image-guided structural and functional visualization systems for individualizing treatment. • Highlight new surgical imaging analysis tools for understanding complex 3D anatomy. • Review advances in three-dimensional printing for surgical planning and patient-specific implant designs. • Develop familiarity with next-generation imaging probes and paradigms for guiding therapeutic interventions, biopsies, and surgical decision-making. • Facilitate integration of next-generation intraoperative tools into clinical trial designs and routine practice. Additional details will be posted as soon as they are available.